NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
George E Duran
Stanford University - Stanford / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1651456
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
George E Duran's MOST POPULAR ARTICLES
1-)
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells JAIDS Journal of Acquired Immune Deficiency Syndromes 19 (3), 203-209, 1998
2-)
Tumor Necrosis Factor-α–Induced Protein 3 As a Putative Regulator of Nuclear Factor-κB–Mediated Resistance to O6-Alkylating Agents in Human Glioblastomas Journal of clinical oncology 24 (2), 274-287, 2006
3-)
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol) Cancer research 56 (5), 1091-1097, 1996
4-)
Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers Molecular oncology 8 (7), 1231-1239, 2014
5-)
Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancersF Moisan, EB Francisco, A Brozovic, GE Duran, YC Wang, S Chaturvedi, ...Molecular oncology 8 (7), 1231-1239, 20141312014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept